EGFR and cancer: Significantly, Cilengitide treatment inhibited the augmented colony formation and invasive potential seen in EGFR‐mutated cancer cells treated with placebo, which were exposed to CM from PCs along with TKI drugs (Figures 3K,L; Figures S3L,M, Supporting Information).